MORNING NEWS

Market strategy by Swissquote Analysts

Micron Shares Jump as Chip Shortage Projected to Last Beyond 2027

By Nadine PEREIRA
Jun 24, 2026
Micron MU Technology, which has seen its value triple this year, said revenue quadrupled in the second quarter and forecast that rapid growth will continue due to near-insatiable demand for its memory chips. Shares surged by as much as 15% in after-hours trading after the company beat Wall Street expectations in virtually every financial metric watched closely by investors, including sales, earnings per share and adjusted gross margin.

FedEx Revenue Rises on Growth in Package Yields, Volume

By Nadine PEREIRA
Jun 23, 2026
FedEx FDX logged higher revenue in its latest quarter on higher shipping rates and volumes. The shipping company’s profit ticked down in the quarter, hurt by costs related to the spin off of its freight operations, business optimization and shift to reporting on a calendar-year basis. Shares declined 6.2% to $297.50 in late trading on Tuesday. At the market close, shares were up 36% year to date. Shares of economic bellwether FedEx FDX fell in late trading despite the delivery giant’s reported increase in quarterly package volumes and revenue.

Lonza Publishes Restated Half-Year 2025 Financials

By Nadine PEREIRA
Jun 22, 2026
Prior to the release of its Half-Year 2026 results on 22 July, Lonza has published restated Half-Year 2025 financial information reflecting the classification of its CHI business as discontinued operations, in line with its Full-Year 2025 reporting. In December 2024, Lonza announced its intention to divest the CHI business.

SoftBank-Backed Robot Maker Gears Up for Hong Kong IPO

By Nadine PEREIRA
Jun 21, 2026
Chinese robotics company Coowa is gearing up to go public in Hong Kong, people familiar with the matter said, joining the wave of robotics and tech companies raising capital in the city. The SoftBank Group backed company’s valuation stood at more than $3 billion after it raised more than $600 million in its latest funding round, the people said. Shanghai-based Coowa plans to file the IPO application within the next two to three months, they added.

Moderna Stock Rises on Flu-Shot Recommendation

By Nadine PEREIRA
Jun 18, 2026
Moderna shares rose 3.5% Thursday after an advisory committee voted to recommend the U.S. Food and Drug Administration approve the biotech’s proposed new flu shot for people 50 and older. The FDA had initially declined to consider Moderna’s application for the shot’s approval but then agreed to review it after Moderna amended it. The advisory committee vote in favor of the vaccine isn’t binding, but the FDA generally follows such recommendations.

Warsh Overhauls How the Fed Talks and Keeps Markets Guessing on Rates

By Nadine PEREIRA
Jun 17, 2026
The Federal Reserve’s first statement under Chairman Kevin Warsh clocked in at only 132 words. Wall Street was troubled by the final six of them. “The Committee will deliver price stability.” The central bank held its benchmark rate steady, as expected, in Kevin Warsh’s first meeting as Fed chairman. But officials’ quarterly economic projections showed that nine of 19 officials penciled in at least one rate increase by the end of the year, up from none in March.

Sandoz Steps up In-house Biosimilar Capabilities

By Nadine PEREIRA
Jun 16, 2026
Sandoz today inaugurates a new biosimilar development centre in Ljubljana, Slovenia, to strengthen and expand its in‑house biosimilar capabilities. The fully digitally integrated USD 99 million facility covers about 10,000 m² and employs more than 200 scientists. It supports end-to-end drug substance and drug product development, backed by advanced analytics and data science.

Siegfried Strengthens Manufacturing Network with New Drug Substance Facility

By Nadine PEREIRA
Jun 15, 2026
Siegfried, a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry headquartered in Zofingen, Switzerland, today inaugurates its new large-scale production facility for API manufacturing in Minden, Germany. The facility adds 100 m³ of reactor capacity and strengthens Siegfried's position as one of the leading global CDMOs for small molecule drug substances.

SpaceX, Now Worth $2.2 Trillion, Pulls Off Goldilocks Debut

By Nadine PEREIRA
Jun 14, 2026
Shares in SpaceX soared 19% Friday as Elon Musk’s rocket maker pulled off the largest initial public offering ever and one of the smoothest in recent history. The company, valued at $1.77 trillion when it sold $75 billion worth of shares a day earlier, ended its first day of trading with a market value of around $2.2 trillion, putting it ahead of Broadcom and Tesla to make it the sixth-most valuable public company in the U.S. The offering handed longstanding SpaceX investors and employees billions in collective gains and turned Musk into the world’s first trillionaire.

Oracle Reports Higher Profit on Surging Cloud Revenue

By Nadine PEREIRA
Jun 10, 2026
ORCL reported higher profit as surging revenue from it cloud infrastructure business more than offset a decline in its software during the fourth quarter. The cloud-computing and software company on Wednesday reported a 47% increase in its cloud revenue, to $9.9 billion, which includes a 93% increase in cloud-infrastructure revenue. Growth in the company’s Oracle Cloud Infrastructure business reflects continuing strong demand for artificial-intelligence computing workloads, co-Chief Executive Officer Clay Magouyrk said on an analyst call. “AI infrastructure makes the existing cloud infrastructure market look small. Everything we see shows this market size is trillions of dollars per year,” Magouyrk said.
Switzerland

Designed with passion in Switzerland

General Information

This website is operated jointly by Swissquote MEA Ltd. ("SQMEA") and Swissquote Bank SA’s Representative Office in Dubai (the "Swissquote Representative Office"). SQMEA is incorporated in the Dubai International Financial Centre ("DIFC") and regulated by the Dubai Financial Services Authority ("DFSA"). The Swissquote Representative Office is licensed by the Central Bank of the United Arab Emirates to carry out representative office activities only. Swissquote Bank SA ("SQB") is incorporated in Switzerland and regulated by the Swiss Financial Market Supervisory Authority (FINMA).
 
Depending on the section of the website, products and services presented may be promoted by SQMEA or by the Swissquote Representative Office. In particular, SQMEA does not promote, arrange or offer to Retail Clients access to any services relating to contracts for differences (CFDs), rolling spot foreign exchange, or other Restricted Speculative Investments, as defined in the DFSA Rulebook (www.dfsa.ae).
 
SQMEA operates multiple business lines. For the target audience of this website, all products and services presented are offered by SQB.
 
No Offer or Advice
The content of this website is provided for information purposes only and does not constitute investment advice, a recommendation, a solicitation, or an offer to buy or sell any financial instruments.
Nothing on this website should be relied upon as the sole basis for making investment decisions. Visitors should seek independent financial, legal, and tax advice before making any investment.
 
Product Availability and Eligibility
Access to products and services described on this website is subject to applicable laws, regulations, and eligibility requirements.
Certain products or services may not be available in all jurisdictions or to all clients, and additional conditions or restrictions may apply.
 
Risk Warning
Investing in financial instruments involves risk, including the possible loss of capital. Past performance is not a reliable indicator of future results.
Further information is available in the "Risks Involved in Trading Financial Instruments" disclosure.

AI-Generated Content

Some visual or editorial content on this website may be generated or enhanced using artificial intelligence (AI) tools.
All such content is subject to human review and approval to ensure accuracy, appropriateness, and compliance with applicable regulatory requirements. AI is not used to provide personalised investment advice, suitability assessments, or client-specific recommendations.